Detailed Information on Publication Record
2023
Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic
KUBÍČEK, Luboš, Radek VITASEK, David SCHWARZ, Robert STAFFA, Petr STRAKOS et. al.Basic information
Original name
Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic
Authors
KUBÍČEK, Luboš (203 Czech Republic, guarantor, belonging to the institution), Radek VITASEK (203 Czech Republic), David SCHWARZ (203 Czech Republic), Robert STAFFA (203 Czech Republic, belonging to the institution), Petr STRAKOS (203 Czech Republic) and Stanislav POLZER (203 Czech Republic)
Edition
Diagnostics, Basel, MDPI, 2023, 2075-4418
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30212 Surgery
Country of publisher
Sweden
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.600 in 2022
RIV identification code
RIV/00216224:14110/23:00130353
Organization unit
Faculty of Medicine
UT WoS
000909283300001
Keywords in English
abdominal aortic aneurysm; biomechanics; rupture risk; predictability; COVID-19
Tags
International impact, Reviewed
Změněno: 19/2/2024 15:23, Mgr. Tereza Miškechová
Abstract
V originále
Background: The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients. This leads to the postponement of elective surgeries including the treatment of abdominal aortic aneurysm (AAA). The probabilistic rupture risk index (PRRI) recently showed its advantage over the diameter criterion in AAA rupture risk assessment. Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion. The objective of this study was to test the clinical applicability of the PRRI method in a quasi-prospective patient cohort study. Methods: Nineteen patients (fourteen males, five females) with intact AAA who were postponed due to COVID-19 pandemic were included in this study. The PRRI was calculated at the baseline via finite element method models. If a case was diagnosed as high risk (PRRI > 3%), the patient was offered priority in AAA intervention. Cases were followed until 10 September 2021 and a number of false positive and false negative cases were recorded. Results: Each case was assessed within 3 days. Priority in intervention was offered to two patients with high PRRI. There were four false positive cases and no false negative cases classified by PRRI. In three cases, the follow-up was very short to reach any conclusion. Conclusions: Integrating PRRI into clinical workflow is possible. Longitudinal validation of PRRI did not fail and may significantly decrease the false positive rate in AAA treatment.